NEW YORK, Nov. 23, 2016 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Colorado, Denver Division on behalf of investors who purchased Pilgrim’s Pride Corporation (NASDAQ:PPC) securities between February 21, 2014 and October 6, 2016.
Click here to learn about the case: http://www.wongesq.com/pslra/pilgrims-pride. There is no cost or obligation to you.
According to the complaint, during the Class Period Pilgrim’s Pride made false and/or misleading statements and/or failed to disclose that: (i) Pilgrim’s Pride systematically colluded with several of its industry peers to fix prices in the broiler-chicken market; (ii) the foregoing constituted a violation of federal antitrust laws; (iii) consequently, the Company’s public statements were materially false and misleading at all relevant times.
If you suffered a loss in Pilgrim’s Pride you have until December 19, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/pilgrims-pride.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]


Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions 



